Rapid identification and tracking of SARS-CoV-2 variants of concern.
作者信息
Chakraborty Debojyoti, Agrawal Anurag, Maiti Souvik
机构信息
CSIR-Institute of Genomics and Integrative Biology, New Delhi 110025, India; Academy of Scientific and Innovative Research, Ghaziabad, India.
CSIR-Institute of Genomics and Integrative Biology, New Delhi 110025, India; Academy of Scientific and Innovative Research, Ghaziabad, India.
出版信息
Lancet. 2021 Apr 10;397(10282):1346-1347. doi: 10.1016/S0140-6736(21)00470-0. Epub 2021 Mar 23.
Abstract
摘要
相似文献
1
Rapid identification and tracking of SARS-CoV-2 variants of concern.快速识别和追踪严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的变异株。
Lancet. 2021 Apr 10;397(10282):1346-1347. doi: 10.1016/S0140-6736(21)00470-0. Epub 2021 Mar 23.
2
CRISPR-Cas12a-Based Detection for the Major SARS-CoV-2 Variants of Concern.基于 CRISPR-Cas12a 的主要关注 SARS-CoV-2 变体检测。
Microbiol Spectr. 2021 Dec 22;9(3):e0101721. doi: 10.1128/Spectrum.01017-21. Epub 2021 Nov 17.
3
CLEVER assay: A visual and rapid RNA extraction-free detection of SARS-CoV-2 based on CRISPR-Cas integrated RT-LAMP technology.CLEVER 检测法：一种基于 CRISPR-Cas 整合 RT-LAMP 技术的可视化、快速免 RNA 提取的 SARS-CoV-2 检测方法。
J Appl Microbiol. 2022 Aug;133(2):410-421. doi: 10.1111/jam.15571. Epub 2022 Apr 18.
4
iSCAN: An RT-LAMP-coupled CRISPR-Cas12 module for rapid, sensitive detection of SARS-CoV-2.iSCAN：一种 RT-LAMP 耦合 CRISPR-Cas12 模块，用于快速、灵敏地检测 SARS-CoV-2。
Virus Res. 2020 Oct 15;288:198129. doi: 10.1016/j.virusres.2020.198129. Epub 2020 Aug 18.
5
Detection of Major SARS-CoV-2 Variants of Concern in Clinical Samples via CRISPR-Cas12a-Mediated Mutation-Specific Assay.通过 CRISPR-Cas12a 介导的突变特异性检测分析在临床样本中检测主要 SARS-CoV-2 关注变体。
ACS Synth Biol. 2022 May 20;11(5):1811-1823. doi: 10.1021/acssynbio.1c00643. Epub 2022 Apr 28.
6
Ultrasensitive and visual detection of SARS-CoV-2 using all-in-one dual CRISPR-Cas12a assay.基于一体式双 CRISPR-Cas12a assay 的 SARS-CoV-2 超灵敏可视化检测
Nat Commun. 2020 Sep 18;11(1):4711. doi: 10.1038/s41467-020-18575-6.
7
Detection of SARS-CoV-2 by CRISPR/Cas12a-Enhanced Colorimetry.通过 CRISPR/Cas12a 增强比色法检测 SARS-CoV-2。
ACS Sens. 2021 Mar 26;6(3):1086-1093. doi: 10.1021/acssensors.0c02365. Epub 2021 Mar 8.
8
COVID-19 and the CRISPR Community Response.新冠疫情与基因编辑技术社区的应对举措
CRISPR J. 2020 Apr;3(2):66-67. doi: 10.1089/crispr.2020.29092.rba.
9
COVID-19 one year later: a retrospect of CRISPR-Cas system in combating COVID-19.COVID-19 一年后：CRISPR-Cas 系统抗击 COVID-19 的回顾。
Int J Biol Sci. 2021 May 13;17(8):2080-2088. doi: 10.7150/ijbs.60655. eCollection 2021.
10
CRISPR-Cas12a-Based Detection of SARS-CoV-2 Harboring the E484K Mutation.基于 CRISPR-Cas12a 的 SARS-CoV-2 携带 E484K 突变的检测。
ACS Synth Biol. 2021 Dec 17;10(12):3595-3599. doi: 10.1021/acssynbio.1c00323. Epub 2021 Nov 16.
引用本文的文献
1
Nanobody against SARS-CoV-2 non-structural protein Nsp9 inhibits viral replication in human airway epithelia.针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）非结构蛋白Nsp9的纳米抗体可抑制病毒在人气道上皮细胞中的复制。
Mol Ther Nucleic Acids. 2024 Aug 15;35(3):102304. doi: 10.1016/j.omtn.2024.102304. eCollection 2024 Sep 10.
2
Discriminative Identification of SARS-CoV-2 Variants Based on Mass-Spectrometry Analysis.基于质谱分析的新型冠状病毒变异株鉴别
Biomedicines. 2023 Aug 24;11(9):2373. doi: 10.3390/biomedicines11092373.
3
Characterization of the expressed RNA variants from young patients with critical and non-critical SARS-CoV-2 infection.对患有重症和非重症新型冠状病毒肺炎（SARS-CoV-2）感染的年轻患者中表达的RNA变体的表征。
Egypt J Med Hum Genet. 2022;23(1):115. doi: 10.1186/s43042-022-00327-4. Epub 2022 Aug 3.
4
Impedimetric Sensing: An Emerging Tool for Combating the COVID-19 Pandemic.阻抗传感：应对 COVID-19 大流行的新兴工具。
Biosensors (Basel). 2023 Jan 30;13(2):204. doi: 10.3390/bios13020204.
5
[Recent advances in clustered regularly interspaced short palindromic repeats-based detection of severe acute respiratory syndrome coronavirus 2].基于成簇规律间隔短回文重复序列的严重急性呼吸综合征冠状病毒2检测的最新进展
Se Pu. 2022 Sep;40(9):773-781. doi: 10.3724/SP.J.1123.2022.08001.
6
Human Fc-Conjugated Receptor Binding Domain-Based Recombinant Subunit Vaccines with Short Linker Induce Potent Neutralizing Antibodies against Multiple SARS-CoV-2 Variants.具有短连接子的基于人Fc结合受体结构域的重组亚单位疫苗可诱导针对多种新冠病毒变异株的强效中和抗体。
Vaccines (Basel). 2022 Sep 8;10(9):1502. doi: 10.3390/vaccines10091502.
7
Diagnostics of COVID-19 Based on CRISPR-Cas Coupled to Isothermal Amplification: A Comparative Analysis and Update.基于CRISPR-Cas与等温扩增联用的新型冠状病毒肺炎诊断：比较分析与进展
Diagnostics (Basel). 2022 Jun 10;12(6):1434. doi: 10.3390/diagnostics12061434.
8
Simplified Cas13-based assays for the fast identification of SARS-CoV-2 and its variants.基于简化 Cas13 的检测方法可快速鉴定 SARS-CoV-2 及其变体。
Nat Biomed Eng. 2022 Aug;6(8):932-943. doi: 10.1038/s41551-022-00889-z. Epub 2022 May 30.
9
A New Way to Trace SARS-CoV-2 Variants Through Weighted Network Analysis of Frequency Trajectories of Mutations.通过对突变频率轨迹进行加权网络分析来追踪新冠病毒变异株的新方法。
Front Microbiol. 2022 Mar 16;13:859241. doi: 10.3389/fmicb.2022.859241. eCollection 2022.
10
Quarantine and testing strategies to ameliorate transmission due to travel during the COVID-19 pandemic: a modelling study.改善2019冠状病毒病大流行期间因旅行导致传播的检疫和检测策略：一项建模研究
Lancet Reg Health Eur. 2022 Mar;14:100304. doi: 10.1016/j.lanepe.2021.100304. Epub 2022 Jan 10.
本文引用的文献
1
FnCas9-based CRISPR diagnostic for rapid and accurate detection of major SARS-CoV-2 variants on a paper strip.基于 FnCas9 的 CRISPR 诊断技术可在纸条上快速准确地检测主要 SARS-CoV-2 变体。
Elife. 2021 Jun 9;10:e67130. doi: 10.7554/eLife.67130.
2
Genomic sequencing in pandemics.大流行中的基因组测序。
Lancet. 2021 Feb 6;397(10273):445. doi: 10.1016/S0140-6736(21)00257-9.
3
New variant of SARS-CoV-2 in UK causes surge of COVID-19.英国出现的新冠病毒新变种导致新冠肺炎病例激增。
Lancet Respir Med. 2021 Feb;9(2):e20-e21. doi: 10.1016/S2213-2600(21)00005-9. Epub 2021 Jan 5.
4
Emergence of a Highly Fit SARS-CoV-2 Variant.一种高度适应的严重急性呼吸综合征冠状病毒2变体的出现。
N Engl J Med. 2020 Dec 31;383(27):2684-2686. doi: 10.1056/NEJMcibr2032888. Epub 2020 Dec 16.
5
CRISPR-Cas System: An Approach With Potentials for COVID-19 Diagnosis and Therapeutics.CRISPR-Cas 系统：一种具有用于 COVID-19 诊断和治疗潜力的方法。
Front Cell Infect Microbiol. 2020 Nov 2;10:576875. doi: 10.3389/fcimb.2020.576875. eCollection 2020.
Zotero 插件